FDA Inspection 1137645 — Matrix Pharmacorp Private Limited

Matrix Pharmacorp Private Limited — FEI 3008861594

The FDA completed an inspection of Matrix Pharmacorp Private Limited on November 23, 2019 in Visakhapatnam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 23, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Visakhapatnam (India)

Additional Details

Mutual Recognition Agreement (MRA)